After registering positive results against the Omicron variant in clinical trials, the VidPrevtyn Beta serum developed by Sanofi has received the green light from the European Medicines Agency.
The European Medicines Agency (EMA) announced this Thursday that it has given the green light to the new generation vaccine used as a booster dose against Covid-19 developed by the French company Sanofi, which has tested positive for the Omicron variant during clinical trials.
The VidPrevtyn Beta serum could be used as a booster dose in adults previously immunized with injections of mRNA vaccines such as Pfizer and Moderna, or virus-vectored vaccines made by AstraZeneca and Johnson & Johnson, the European regulator said in a statement.
>> More information to come on BFM Business in a few moments. Also find live videos of BFM Business and Follow us on Twitter.
Source: BFM TV
